Who Paid My Doc
VERSANT kPCR Molecular System SP
Device DX - Diagnostics incl. all products and services
PDI 00630414541457
General payments
$9,056
Research payments
$0
Through program year 2023, $9,056 in general payments and $0 in research payments were reported against VERSANT kPCR Molecular System SP (DX - Diagnostics incl. all products and services).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $92 | 1 |
| 2022 | General | $965 | 21 |
| 2021 | General | $8,000 | 5 |
Breakdown
Each share is of general payments naming this product in 2023.
Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2023 where a state was reported.
Records
27 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.